Research progress of nanotechnology in circulating tumor cell

Abstract

Gao Yang, Yuan Zhou. Research progress of nanotechnology in circulating tumor cell[J]. Journal of International Oncology, 2015, 42(1): 46-48.

［1］ He S, Li P, He S, et al. Detection of circulating tumour cells with the CellSearch system in patients with advancedstage head and neck cancer: preliminary results［J］. J Laryngol Otol, 2013, 127(8): 788-793. ［2］ Andreopoulou E, Yang LY, Rangel KM, et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest Breast Cancer Select/DetectTM versus Veridex Cell SearchTM system［J］. Int J Cancer, 2012, 130(7): 1590-1507. ［3］ Wu CH, Huang YY, Chen P, et al. Versatile immunomagnetic nanocarrier platform for capturing cancer cells［J］. ACS Nano, 2013, 7(10): 8816-8823. ［4］ Haun JB, Castro CM, Wang R, et al. MicroNMR for rapid molecular analysis of human tumor samples［J］. Sci Transl Med, 2011, 3(71): 71ra16. ［5］ Medley CD, Smith JE, Tang Z, et al. Gold nanoparticlebased colorimetric assay for the direct detection of cancerous cells［J］. Anal Chem, 2008, 80(4): 1067-1072. ［6］ Kim S, Han SI, Park MJ, et al. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads［J］. Anal Chem, 2013, 85(5): 2779-2786. ［7］ Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer［J］. J Oncol, 2010, 2010: 617421. ［8］ Bonnomet A, Brysse A, Tachsidis A, et al. Epithelialtomesenchymal transitions and circulating tumor cells［J］. J Mammary Gland Biol Neoplasia, 2010, 15(2): 261-273. ［9］ Gorges TM, Tinhofer I, Drosch M, et al. Circulating tumour cells escape from EpCAMbased detection due to epithelialtomesenchymal transition［J］. BMC Cancer, 2012, 12: 178. ［10］ Deng G, Herrler M, Burgess D, et al. Enrichment with anticytokeratin alone or combined with antiEpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients［J］. Breast Cancer Res, 2008, 10(4): R69. ［11］ Lee HJ, Cho HY, Oh JH, et al. Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles［J］. Biosens Bioelectron, 2013, 47: 508-514. ［12］ Ghazani AA, Castro CM, Gorbatov R, et al. Sensitive and direct detection of circulating tumor cells by multimarker μnuclear magnetic resonance［J］. Neoplasia, 2012, 14(5): 388-395. ［13］ Huang YF, Chang HT, Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods［J］. Anal Chem, 2008, 80(3): 567-572. ［14］ Rana K, Liesveld JL, King MR. Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and Eselectin［J］. Biotechnol Bioeng, 2009, 102(6): 1692-1702. ［15］ Neves LF, Krais JJ, Van Rite BD, et al. Targeting singlewalled carbon nanotubes for the treatment of breast cancer using photothermal therapy［J］. Nanotechnology, 2013, 24(37): 375104. ［16］ Hossain M, Luo Y, Sun Z, et al. Xray enabled detection and eradication of circulating tumor cells with nanoparticles［J］. Biosens Bioelectron, 2012, 38(1): 348-354.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[4]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[5]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[6]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[7]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[8]	Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311.
[9]	Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(4): 210-216.
[10]	Hu Tingting, Wang Yuehua.Electronic nose and nematode nose as new tool for early cancer screening[J]. Journal of International Oncology, 2024, 51(4): 223-226.
[11]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[12]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[13]	Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes[J]. Journal of International Oncology, 2024, 51(3): 143-150.
[14]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[15]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.

Research progress of nanotechnology in circulating tumor cell

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments